Cargando…

HIV-1 replication changes the function of the PKR activator PACT

Detalles Bibliográficos
Autores principales:	Clerzius, Guerline, Shaw, Eileen, Daher, Aïcha, Burugu, Samantha, Gélinas, Jean-François, Routy, Jean-Pierre, Patel, Rekha C, Gatignol, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847834/ http://dx.doi.org/10.1186/1742-4690-10-S1-P35

Ejemplares similares

The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication
por: Clerzius, Guerline, et al.
Publicado: (2013)

Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity?
por: Gatignol, Anne, et al.
Publicado: (2005)

Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT
por: Dabo, Stephanie, et al.
Publicado: (2017)

Inhibition of HIV-1 expression and replication by SOFA-HDV ribozymes against Tat and Rev mRNA sequences
por: Lainé, Sébastien, et al.
Publicado: (2009)

Neuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism
por: Mouton-Liger, François, et al.
Publicado: (2013)

Peripheral inflammation increases PKR activation, Tau phosphorylation and amyloid β production in wild-type mice
por: Mouton-Liger, François, et al.
Publicado: (2013)

Treatment with aripiprazole once-monthly injectable formulation is effective in improving symptoms and global functioning in schizophrenia with and without comorbid substance use – a post hoc analysis of the ReLiAM study
por: Margolese, Howard C., et al.
Publicado: (2022)

PACT-mediated PKR activation acts as a hyperosmotic stress intensity sensor weakening osmoadaptation and enhancing inflammation
por: Farabaugh, Kenneth T, et al.
Publicado: (2020)

Developing an intervention to support lung cancer patients and their clinicians when considering systemic anti-cancer therapy: pact study
por: Nelson, Annmarie, et al.
Publicado: (2013)

MicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells
por: Nakamura, Masato, et al.
Publicado: (2015)

HIV experts on the decision to use early ART for prevention in France: are we there yet?
por: Lebouché, Bertrand, et al.
Publicado: (2012)

Profiling of coexpression of multiple immune checkpoints in the CD4+ and CD8+ T cell components of the clear cell renal cell carcinoma immune infiltrate
por: Monette, Anne, et al.
Publicado: (2015)

P1485: PKM AND PKR EXPRESSION DURING HEMATOPOIESIS AND ERYTHROPOIESIS
por: Tsai, Erin, et al.
Publicado: (2023)

Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study
por: Mustafa, Sally, et al.
Publicado: (2019)

ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
por: Cachat, Anne, et al.
Publicado: (2014)

Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study
por: Chokka, Pratap, et al.
Publicado: (2021)

The antisense protein of HTLV-2 positively modulates HIV-1 replication
por: Torresilla, Cynthia, et al.
Publicado: (2014)

P16-54 LB. Blood CCR6+ Th17 and Th1Th17 but not CCR6neg Th1 cells are targets for HIV replication and their frequency is diminished in HIV-infected subjects
por: Gosselin, A, et al.
Publicado: (2009)

Luteolin protects DYT-PRKRA cells from apoptosis by suppressing PKR activation
por: Frederick, Kenneth, et al.
Publicado: (2023)

Translational research at acute HIV Infection
por: Routy, Jean Pierre
Publicado: (2010)

Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies
por: Schöttle, Daniel, et al.
Publicado: (2022)

Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
por: Oluboka, Oloruntoba, et al.
Publicado: (2023)

Hepatitis C Virus Controls Interferon Production through PKR Activation
por: Arnaud, Noëlla, et al.
Publicado: (2010)

Stress-induced TRBP phosphorylation enhances its interaction with PKR to regulate cellular survival
por: Chukwurah, Evelyn, et al.
Publicado: (2018)

ADAR1 and PACT contribute to efficient translation of transcripts containing HIV-1 trans-activating response (TAR) element
por: Chukwurah, Evelyn, et al.
Publicado: (2017)

Automated HTS/HCS for antivirals using visual HIV full replication assays
por: Carralot, Jean-Philippe, et al.
Publicado: (2009)

Developing a framework for replication of research in implementation science
por: Curran, Janet, et al.
Publicado: (2014)

A new role of the HIV-1 nucleocapsid in the spatiotemporal control of the reverse transcription throughout the virus replication cycle
por: Yu, Bing, et al.
Publicado: (2009)

P032 Prospective Crossover Trial of Positional and Continuous Positive Airway Pressure Therapy (PaCT) for the Treatment of Mild-to-Moderate Positional Obstructive Sleep Apnoea
por: Kinder, S, et al.
Publicado: (2023)

PKR involvement in Alzheimer’s disease
por: Hugon, Jacques, et al.
Publicado: (2017)

Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication
por: Di Nunzio, Francesca, et al.
Publicado: (2013)

PKR-mediated stress response enhances dengue and Zika virus replication
por: Ricciardi-Jorge, Taissa, et al.
Publicado: (2023)

Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure?
por: Tallon, B, et al.
Publicado: (2012)

Cellular suicide pact
por: Williams, Ruth
Publicado: (2007)

Observation of AGNs with PACT
por: Bose, D
Publicado: (2005)

Forced primer selection modulates HIV-1 replication and stability of the PBS
por: Ni, Na, et al.
Publicado: (2006)

Control of HIV replication by a novel constitutively active ‘super-PRR’
por: Gupta, S, et al.
Publicado: (2012)

PKR Activation Favors Infectious Pancreatic Necrosis Virus Replication in Infected Cells
por: Gamil, Amr A.A., et al.
Publicado: (2016)

P15-02. Participation in immune-based therapy trial excludes participation in future trials: solving this problem
por: Routy, J, et al.
Publicado: (2009)

Treating since the beginning?
por: Routy, Jean-Pierre
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b8e0m2astjom8cr6j4ifelsv5p